Overexpression of Cyclin D1 in Accelerated-Phase Chronic Myeloid Leukemia

References

• Kantarjian, H.M., Deisseroth, A., Kurzrock, R., Estrov, Z. and Talpaz, M. (1993) "Chronic myelogenous leukemia: a concise update", Blood, 82, 691–703.
   Google Scholar
• Lugo, T.G., Pendergast, A.M., Muller, A.J. and Witte, ON. (1990) "Tyrosine lcinase activity and transformation potency of bcr-abl oncogene products", Science, 247, 1079— 1082.
   Google Scholar
• Daley, G.Q., Van Etten, R.A. and Baltimore, D. (1990) "Induction of chronic myelogenous leukemia in mice by the P2I0bcr/abl gene of the Philadelphia chromosome", Science, 247, 824–830.
   PubMed Web of Science ®Google Scholar
• Faderl, S., Talpaz, M., Estrov, Z. and Kantarjian, H.M. (1999) "Chronic myelogenous leukemia: biology and therapy", Annals of Internal Medicine, 131, 207–219.
   PubMed Web of Science ®Google Scholar
• Goldman, J.M. and Melo, J.V. (2002) "Chronic myeloid leukemia", New England Journal of Medicine, 349, 1451–1464.
   Web of Science ®Google Scholar
• Gaiger, A., Henn, T., Horth, E., Geissler, K., Mitterbauer, G., Maier-Dobersberger, T., et al. (1995) "Increase of BCR-ABL chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression", Blood, 86, 2371–2378.
   PubMed Web of Science ®Google Scholar
• Kelliher, MA., McLaughlin, J., Witte, ON. and Rosenberg, N. (1990) "Induction of a chronic myelogenous leukemia-like syn-drome in mice with v-abl and BCR/ABL", Proceedings of the National Academy of Sciences of the United States of America, 87, 6649–6653.
   Google Scholar
• Chen, Y.Y. and Rosenberg, N. (1992) "Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine lcinase only during early GI", Proceedings of the National Academy of Sciences of the United States of America, 89, 6683–6687.
   Google Scholar
• Gishizky, ML., Johnson-White, J. and Witte, ON. (1993) "Efficient transplantation of BCR-ABL-induced chronic myelogen-ous leukemia-like syndrome in mice", Proceedings of the National Academy of Sciences of the United States of America, 90, 3755 — 3759.
   PubMed Web of Science ®Google Scholar
• Sonoyama, J., Matsumura, I., Ezoe, S., Satoh, Y., Zhang, X., Kataoka, Y., et al. (2002) "Functional cooperation among Ras, STAT5, and phosphatidylinositol 3-lcinase is required for full oncogenic activities of BCR/ABL in K562 cells", Journal of Biological Chemistry, 277, 8076–8082.
   PubMed Web of Science ®Google Scholar
• Skorslci, T., Kanakaraj, P., Nieborowska-Skorska, M., Ratajczak, M.Z., Wen, S.C., Zon, G., et al. (1995) "Phosphatidylinosito1-3 lcinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells", Blood, 86, 726–736.
   PubMed Web of Science ®Google Scholar
• Goga, A., McLaughlin, J., Afar, D.E., Saffran, D.C. and Witte, ON. (1995) "Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene", Cell, 82, 981–988.
   Google Scholar
• Horita, M., Andreu, E.J., Benito, A., Arbona, C., Sanz, C., Benet, I., et al. (2000) "Blockade of the Bcr-Abl lcinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bc1-xL", Journal of Experimental Medicine, 191, 977–984.
   PubMed Web of Science ®Google Scholar
• Nieborowska-Skorska, M., Wasik, MA., Slupianek, A., Salomoni, P., Kitamura, T., Calabretta, B., et al. (1999) "Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and 5H2 domains of BCR/ABL and is required for leukemogenesis", Journal of Experimental Medicine, 189, 1229 — 1242.
   PubMed Web of Science ®Google Scholar
• Alvarez, B., Garrido, E., Garcia-Sanz, J.A. and Carrera, A.C. (2003) "Phosphoinositide 3-lcinase activation regulates cell division time by coordinated control of cell mass and cell cycle progression rate", Journal of Biological Chemistry, 278, 26466— 26473.
   Web of Science ®Google Scholar
• Di Cristofano, A., Nilci, M., Zhao, M., Karnell, F.G., Clarkson, B., Pear, W.S., et al. (2001) "p62(dok), a negative regulator of Ras and mitogen-activated protein lcinase (MAPK) activity, opposes leuke-mogenesis by p210(bcr-abl)", Journal of Experimental Medicine, 194, 275–284.
   PubMed Web of Science ®Google Scholar
• Sherr, C.J. and Roberts, J.M. (1999) "CDK inhibitors: positive and negative regulators of GI-phase progression", Genes and Develop-ment, 13, 1501–1512.
   Google Scholar
• Afar, D.E., McLaughlin, J., Sherr, CJ., Witte, ON. and Roussel, M.F. (1995) "Signaling by ABL oncogenes through cyclin DI", Proceedings of the National Academy of Sciences of the United States of America, 92, 9540–9544.
   PubMed Web of Science ®Google Scholar
• Cross, N.C., Feng, L., Chase, A., Bungey, J., Hughes, T.P. and Goldman, J.M. (1993) "Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation", Blood, 82, 1929 — 1936.
   Google Scholar
• Deininger, MM., Goldman, J.M. and Melo, J.V. (2000) "The molecular biology of chronic myeloid leukemia", Blood, 96, 3343 — 3356.
   Google Scholar
• Sawyers, CL., Callahan, W. and Witte, ON. (1992) "Dominant negative MYC blocks transformation by ABL oncogenes", Cell, 70, 901 —910.
   Google Scholar
• Williamson, E.A., Burgess, G.S., Eder, P., Litz-Jackson, S. and Boswell, H.S. (1997) "Cyclic AMP negatively controls c-myc transcription and GI cell cycle progression in p2I0 BCR-ABL transformed cells: inhibitory activity exerted through cyclin DI and cdk4", Leukemia, 11, 73–85.
   Google Scholar
• Jena, N., Deng, M., Sicinska, E., Sicinslci, P. and Daley, G.Q. (2002) "Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells", Cancer Research, 62, 535–541.
   PubMed Web of Science ®Google Scholar
• Parada, Y., Banerji, L., Glassford, J., Lea, N.C., Collado, M., Rivas, C., et al. (2001) "BCR-ABL and interleulcin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip 1 expression", Journal of Biological Chemistry, 276, 23572–23580.
   PubMed Web of Science ®Google Scholar